Deep Tumor Penetrating Gold Nano‐Adjuvant for NIR‐II‐Triggered In Situ Tumor Vaccination

Anhong Chen,Lei Wu,Yao Luo,Shaojin Lu,Yupeng Wang,Zhengzheng Zhou,Dongfang Zhou,Zhigang Xie,Jun Yue
DOI: https://doi.org/10.1002/smll.202200993
IF: 13.3
2022-04-21
Small
Abstract:A nano‐adjuvant system for in‐situ tumor vaccination is fabricated: deep tumor penetrating gold nanostars decorated with hyaluronidases and immunostimulatory oligodeoxynucleotides. Upon tumor irradiation with the near‐infrared light at the second window, the nano‐adjuvant significantly inhibits the tumor growth, generates an obvious adaptive immunity against the re‐challenged cancers, boosts the abscopal effect and completely inhibits the pulmonary metastases.Local tumor photothermal treatment with the near‐infrared light at the second window (NIR‐II) is a promising strategy in triggering the in situ tumor vaccination (ISTV) for cancer therapy. However, limited penetration of photothermal agents within tumors seriously limits their spatial effect in generating sufficient tumor‐associated antigens, a key factor to the success of ISTV. In this study, a nano‐adjuvant system is fabricated based on the NIR‐II‐absorbable gold nanostars decorated with hyaluronidases and immunostimulatory oligodeoxynucleotides CpG for ISTV. The nano‐adjuvant displays a deep tumor penetration capacity via loosening the dense extracellular matrix of tumors. Upon NIR‐II light irradiation, the nano‐adjuvant significantly inhibits the tumor growth, induces a cascade of immune responses, generates an obvious adaptive immunity against the re‐challenged cancers, boosts the abscopal effect, and completely inhibits the pulmonary metastases. The study highlights an advanced nano‐adjuvant formulation featuring deep tumor penetration for NIR‐II‐triggered ISTV.
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
What problem does this paper attempt to address?